Mitchell Sheinkop, MD

Board-Certified Orthopedic Surgeon · Member Emeritus, QC Kinetix Medical Management Team

Dr. Mitchell Sheinkop is a board-certified orthopedic surgeon and Professor Emeritus of Orthopedic Surgery at Rush University Medical Center in Chicago. He is a Member Emeritus of the QC Kinetix Medical Management Team and medically reviews QC Kinetix patient education articles for accuracy.

Credentials 

  • Board certification: Orthopaedic Surgery
  • Medical license: Illinois (NPI 1073592861)
  • Medical degree: Chicago Medical School
  • Fellowships: Pediatric orthopedics; hand surgery
  • Academic appointment: Professor Emeritus of Orthopedic Surgery, Rush University Medical Center (37 years at Rush)
  • Leadership: Former Director, Joint Replacement Program, Rush University Medical Center
  • Surgical experience: More than 20,000 joint replacements
  • Role at QC Kinetix: Member Emeritus, Medical Management Team; medical reviewer for patient education content

Clinical Career

Dr. Sheinkop spent 37 years at Rush University Medical Center in Chicago, where he served as Director of the Joint Replacement Program and Professor of Orthopedic Surgery before becoming Professor Emeritus. A graduate of Chicago Medical School, he completed fellowships in pediatric orthopedics and hand surgery.

He is recognized for his work in complex hip and knee disorders and was an early adopter of computer-assisted navigation, minimally invasive surgical techniques, and hip resurfacing. Over his career, he has performed more than 20,000 joint replacements.

Regenerative Medicine and Research

After decades in joint replacement surgery, Dr. Sheinkop focused his clinical work and research on orthobiologic treatments for joint pain. He has treated more than 500 patients with orthobiologic treatments and has authored or co-authored more than 35 peer-reviewed articles indexed in PubMed, including recent research on concentrated autologous blood products and bone marrow concentrate for knee osteoarthritis pain.

Selected publications

  • Sheinkop M, et al. The Outcomes at 3 Years in 82 Knees with Kellgren and Lawrence 2-3 Osteoarthritis Treated with an Autologous Protein Fluid Concentrate Produced with a Fluid Volume Reducer. Life (Basel), 2024. View on PubMed
  • Panchal J, et al. (including Sheinkop M). Safety and Efficacy of Percutaneous Injection of Lipogems Micro-Fractured Adipose Tissue for Osteoarthritic Knees. American Journal of Orthopedics, 2018. View on PubMed

 

View all of Dr. Sheinkop’s publications on PubMed

Speaking

Dr. Sheinkop is a frequent speaker at national and international regenerative medicine conferences, most recently the International Conference on Regenerative Medicine in Uzbekistan (October 2026), where he presented on bone marrow concentrate and concentrated plasma for knee osteoarthritis pain.

In the Media

Contact Us

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
Chosen Location
Secret Link